Hyperacute stroke care and NHS England's business plan: Computer simulation, coupled with high quality data, can help in decision making

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Monks, Thomas ^a   Pitt, Martin ^a   Stein, Ken ^a   James, Martin A ^b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

AMBULANCE TRANSPORTATION; BRAIN ISCHEMIA; CENTRALIZATION; CEREBROVASCULAR ACCIDENT; COST CONTROL; EDITORIAL; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HEALTH CARE; HUMAN; MEDICAL AUDIT; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RURAL AREA; UNITED KINGDOM;

AMBULANCES; ENGLAND; HEALTH PRIORITIES; HUMANS; MODELS, THEORETICAL; RURAL POPULATION; STATE MEDICINE; STROKE; THROMBOLYTIC THERAPY; TIME-TO-TREATMENT;

EID: 84899851462     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3049     Document Type: Editorial

References (12)

1. NHS England. NHS England's business plan 2014/15-2016/17. Putting patients first. 2014. www.england.nhs.uk/2014/03/31/ppf-business-plan/.
2. Hunter RM, Davie C, Rudd A., Thompson A, Walker H, Thomson N., et al. Impact on clinical and cost outcomes of a centralized approach to acute stroke care in London: a comparative effectiveness before and after model. PLoS One 2013; 8:e70420.
3. Royal College of Physicians. Intercollegiate Stroke Working Party. Sentinel Stroke National Audit programme (SSNAP) July to September 2013. 2014. www.rcplondon.ac.uk/projects/ ssnap-clinical-audit.
4. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-703.
5. IST-3 Collaborative Group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379:2352-63.
6. Meretoja A, Strbian D, Mustanoja S., Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology 2012; 79:306-13.
7. Monks T, Pitt M, Stein K., James M. Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke 2012; 43:2706-11.
8. Pitt M, Monks T, Agarwal P., Worthington D, Ford GA, Lees K.R., et al. Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis? Stroke 2012; 43:2992-7.
9. Lahr MMH, van der Zee D-J, LuijckxG-J, Vroomen PCAJ, Buskens E. A simulation-based approach for improving utilization of thrombolysis in acute brain infarction. Med Care 2013; 51:1101-5.
10. Churilov L, Fridriksdottir A, Keshtkaran M., Mosley I, Flitman A, Dewey HM Decision support in pre-hospital stroke care operations: a case of using simulation to improve eligibility of acute stroke patients for thrombolysis treatment. Comput Operations Res 2013; 40:2208-18.
11. Lahr MMH, van der Zee D-J, Vroomen PCAJ, Luijckx G-J, Buskens E. Thrombolysis in acute ischemic stroke: a simulation study to improve pre- and in-hospital delays in community hospitals. PLoS One 2013; 8:e79049.
12. NHS England. Transforming urgent and emergency care services in England. Urgent and emergency care review. 2013.www.nhs.uk/NHSEngland/keogh-review/ Documents/UECR. Ph1Report.FV.pdf.